Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Medicinas Complementárias
Métodos Terapéuticos y Terapias MTCI
País/Región como asunto
País de afiliación
Intervalo de año de publicación
1.
Mycopathologia ; 182(11-12): 1053-1060, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28736794

RESUMEN

Tinea capitis caused by Microsporum audouinii is reported herein from two Brazilian schoolchildren, which are brothers. Arthroconidia were evidenced on direct examination of scalp hair, and a fungus of the genus Microsporum was isolated from cultures of each patient. The isolated fungi were classified as M. audouinii by visualization of species-specific structures, including: pectinate hyphae, chlamydospores, and fusiform macroconidia, sterile growth with characteristic brown pigment in rice grains, and through DNA sequencing of the internal transcriber spacer region. Patients were refractory to ketoconazole, but the two cases had a satisfactory response to oral terbinafine. All M. audouinii infections described in this century were reviewed, and to our knowledge, this is the first literature description of this species from South America. Misidentification of M. audouinii with Microsporum canis can occur in this area, leading to erroneous data about the occurrence of this species.


Asunto(s)
Antifúngicos/uso terapéutico , Microsporum/aislamiento & purificación , Naftalenos/uso terapéutico , Tiña del Cuero Cabelludo/tratamiento farmacológico , Anciano , Brasil , Niño , Preescolar , ADN Intergénico/genética , Farmacorresistencia Fúngica , Femenino , Cabello/microbiología , Humanos , Cetoconazol/uso terapéutico , Masculino , Pruebas de Sensibilidad Microbiana , Microsporum/efectos de los fármacos , Cuero Cabelludo/microbiología , Piel/microbiología , Terbinafina , Tiña del Cuero Cabelludo/microbiología
2.
In. Universidade Federal do Rio de Janeiro.Instituto de Estudos em Saúde Coletiva. Investigações em sistema de saúde e controle da hanseníase. Rio de Janeiro, s.n, abr.-jun., 2008. p.363-376.
No convencional en Inglés | LILACS, SES-SP, HANSEN, HANSENIASE, SESSP-ILSLACERVO, SES-SP | ID: biblio-1247260

RESUMEN

Single skin lesion, paucibacillary (SSL-PB) leprosy is considered and early disease manifesation. This study the clinical outcome of a cohort of 259 newly diagnosed SSL-PB treated with one dose of rifampicin, ofloxacin, minocycline (ROM) and followed-up for three-years. Patients were recruited from the North, Central West and Southeast regions in Brazil (1997-2001). The result expected with ROM therapy was disappearance or the reduction of lesion size. Manifestation that required additional intervention were considered as poor clinical outcome: type-1 reaction (T1R) with or without neuritis alone, increase in lesion size and shift from paucibacillary to multibacillary. The incidence of poor clinical outcome was calculated by person-month and with the Kaplan-Meier methods. 61.8% of the participants were females, mean age 32.2, and 67,2% had borderline tuberculoid (BT) or tuberculoid forms. T1R was the predominant event; shift from paucibacillary to multibacillaru was rare. 92.0% of the volunteers shown no events during the first year, the same occurring to 80.6% of them after 3 years of clinical monitoring. The probability of remaining event-free was highest among those 40 years old or younger. Poor outcome predominated among BT patients. Extended monitoring of SSL-PB leprosy cases under minimal therapy provided valuable case management information for reference centers.


Asunto(s)
Dosis Única/métodos , Lepra/epidemiología , Lepra/fisiopatología , Lepra/inmunología , Salud Pública/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA